HOME >> BIOLOGY >> NEWS
Sweet success in targeting sugar molecules to cells in living animals

Howard Hughes Medical Institute researchers have successfully targeted unnatural sugar molecules with chemically unique functional groups onto the surfaces of cells in living animals without altering the animals' physiology.

The achievement is a significant advance in the promising new field of metabolic engineering because it provides a new tool with which researchers can label specific cells in whole animals so that they can differentiate one cell from another.

The researchers said the new approach to marking cell-surface sugars could lead to improved understanding of fundamental cellular processes where sugars are known to play an important role, such as in interaction with pathogens, and in mediating inflammation and disease. The research may also make it possible to target the delivery of chemical agents to specific cell types in living organisms more precisely.

Led by Howard Hughes Medical Institute Medical Institute investigator Carolyn R. Bertozziat the University of California, Berkeley, the researchers published their findings in the August 19, 2004, issue of the journal Nature.

"The method introduced by Bertozzi and colleagues is remarkable as a chemical process," wrote David A. Tirrell of the California Institute of Technology in an accompanying News and Views article in Nature. "The fact that specific chemical transformations can now be accomplished with spatial and temporal control in live animals is a major step forward for chemistry."

Glycosylation is the addition of carbohydrate (sugar) groups to a molecule. It has long been known that the glycosylation patterns of sugar molecules on cell surfaces can influence their interaction with other cells. "Glycobiologists have known that cancer cells, for example, exhibit changes in glycosylation patterns when compared with their normal healthy tissue counterparts," said Bertozzi.
'"/>

Contact: Jim Keeley
keeleyj@hhmi.org
301-215-8858
Howard Hughes Medical Institute
18-Aug-2004


Page: 1 2 3 4

Related biology news :

1. Sweet success on the way to vaccine for ulcers, stomach cancer, reported in Science
2. Bakers Yeast Causes Chemical Reactions And Sweet Smelling Labs
3. Inhibition Of A Novel Gene Involved In Phosphorylating Starch In TransgenicPotato Tubers Leads To The Repression Of Cold Induced Sweetening
4. Cancer Cells Self-Destruct When "Sweet Tooth" Is Thwarted
5. Phase II trials of second-generation antisense cancer drug planned following successful early study
6. UCI scientists successfully target key HIV protein; breakthrough may lead to new drug therapies
7. Molecular marker predicts success of breast cancer treatment
8. Ecological success?
9. Land Regeneration Network celebrates first year success
10. Studies show success of Mectizan partnerships
11. Study of dyslexic brain finds three word forms responsible for reading success

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/2/2020)... CITY, Calif. (PRWEB) , ... July 01, 2020 ... ... biotech company, presented its phase 1a findings of Neihulizumab, a biologic for the ... conference in June 2020. Led by hemato-oncologist Dr. Paul J Martin of the ...
(Date:7/1/2020)... ... 2020 , ... Catalent, a global leader in clinical supply ... facility in Minakuchi, located in the Shiga prefecture of Japan. , Operating in ... new 60,000-square-foot facility will provide customers with flexible clinical supply solutions, serving both ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... for biopharmaceutical R&D, today announced that it has entered into a multi-year ... antibodies (Multiclonics®), to support their translational and clinical research strategy to discover ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... ... 09, 2020 , ... In most research using the zebrafish ... formation in zebrafish embryos, maintaining optical transparency to facilitate microscopic imaging. Over the ... using the zebrafish model to investigate the causes of leukaemia and its relationship ...
(Date:7/7/2020)... ... July 06, 2020 , ... ... from Roche, Eli Lilly, Bristol-Myers Squibb, the University of Chicago, Massachusetts General Hospital, ... has hosted an elite awards program, highlighting outstanding examples of how technology innovations ...
(Date:7/1/2020)... ... June 30, 2020 , ... ... data insights, today announced that the launch of a new clinical ... data about the tumor microenvironment (TME). , “Flagship’s TissueInsight is a service ...
(Date:6/28/2020)... Conn. (PRWEB) , ... June 25, 2020 , ... ... formed to advance photodynamic therapy for treating cancer, today announced the company has ... York (“Roswell Park”). The agreement provides Lumeda globally exclusive rights to Roswell ...
Breaking Biology Technology:
Cached News: